CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Stephen F. Betz sold $397K of Crinetics Pharmaceuticals, Inc.
Sold$396,610
$37.37Price
10,612Shares
−7%Stake
What CRNX did after the filing
- The stock from Wed, Mar 18 close, $36.05
- +7.6%
- S&P 500, same days
- +8.7%
Measured over 30 trading days, to the Apr 30 close.
Traded Mon, Mar 16. Filed Wed, Mar 18, 1:11 PM ET, during the session. Returns use the Mar 18 close and the Apr 30 close. Not investment advice.